A clinical trial to study the effect of drug Sarakondrai chooranam in patients having low haemoglobin level

A clinical study on Pitha paandu with the evaluation of Siddha drug Sarakondrai chooranam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008735

Enrollment

Registered

2017-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pitha Paandu (Iron Deficiency Anaemia)

Interventions

Intervention1: Sarakondrai Chooranam: 2 grams of Sarakondrai Chooranam will be administered twice a day with milk for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Hb below 7-10 gms % Fatigue Loss of appetite Pallor of conjunctiva and nail buds Dyspnoea on exertion Ulceration of mouth Worm Infestation(Hook worm)

Exclusion criteria

Exclusion criteria: History of chronic Renal disorders History of chronic Liver disorders History of Thalessemia History of Bleeding disorder Vulnerable Populations such as pregnant women, Lactating mothers ï?¶ TB affected individuals, HIV positive

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed by reduction in clinical symptoms and increase in Haemoglobin level by comparing the parameters before and after treatmentTimepoint: 48 Days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr M Shanmuga priya

Govt Siddha Medical College

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026